Stockreport

Invivyd Updates VYD2311 REVOLUTION Trials, Modestly Upsizes Study, Unveils Measles mAb VMS-063 [Yahoo! Finance]

Invivyd, Inc.  (IVVD) 
PDF the discovery and early development work for a measles monoclonal antibody candidate, VMS-063, during a conference call led by board chairman Marc Elia alongside Chief S [Read more]